计算溶液所需的质量、体积或浓度。
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
E339599-5mg |
5mg |
现货 ![]() |
| |
E339599-10mg |
10mg |
现货 ![]() |
| |
E339599-50mg |
50mg |
现货 ![]() |
| |
E339599-100mg |
100mg |
期货 ![]() |
|
别名 | N6-(氨基亚氨基甲基)-N2-(3-巯基-1-氧丙基)-L-赖氨酰基-L- α-天冬氨酰-L-色氨酸-L-脯氨酰基-L-半胱胺酸环状(16)-二硫乙酸, 环(S,S)-Mpr(Har)GDWPC-NH2乙酸盐 |
---|---|
英文别名 | acetic acid;2-[(3S,6S,12S,20R,23S)-20-carbamoyl-12-[4-(diaminomethylideneamino)butyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,22-hexaoxo-17,18-dithia-1,4,7,10,13,21-hexazabicyclo[21.3.0]hexacosan-6-yl]acetic acid | 1248559-53-6 | L-Cysteinamide,N6-(aminoimino |
规格或纯度 | ≥98% |
英文名称 | Eptifibatide acetate |
生化机理 | 依替巴肽是一种纤维蛋白原与血小板膜整合素糖蛋白 GPIIb/IIIa 受体结合的特异性抑制剂,可防止血小板聚集。 依替巴肽可逆且竞争性结合。 |
储存温度 | -20°C储存 |
运输条件 | 超低温冰袋运输 |
产品介绍 |
醋酸依替巴肽是整联蛋白αIIb(血小板糖蛋白IIb)/整联蛋白β3(血小板糖蛋白IIIa)受体的选择性抑制剂。 Introduction: Eptifibatide acetate is a cyclic heptapeptide. It is the member of the class arginin-glycin-aspartat-mimetics. Eptifibatide has a short half-life. The drug decreases the risk of myocardial infarction (MI). Eptifibatide acetate might be associated with thrombocytopenia. Eptifibatide acetate is a selective inhibitor of Integrin alpha IIb ( platelet glycoprotein IIb) /Integrin beta 3 (platelet glycoprotein IIIa) receptors. |
pKa值 | pKa: 4.01 (Predicted), pKa: 13.51 (Predicted) |
---|---|
IC50 | Integrin αIIb/Integrin β3: IC₅₀= 140 nM (human) |
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
---|
PubChem SID | 504766877 |
---|---|
分子类型 | 小分子 |
IUPAC Name | acetic acid;2-[(3S,6S,12S,20R,23S)-20-carbamoyl-12-[4-(diaminomethylideneamino)butyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,22-hexaoxo-17,18-dithia-1,4,7,10,13,21-hexazabicyclo[21.3.0]hexacosan-6-yl]acetic acid |
INCHI | InChI=1S/C35H49N11O9S2.C2H4O2/c36-30(51)25-18-57-56-13-10-27(47)42-22(8-3-4-11-39-35(37)38)31(52)41-17-28(48)43-23(15-29(49)50)32(53)44-24(14-19-16-40-21-7-2-1-6-20(19)21)34(55)46-12-5-9-26(46)33(54)45-25;1-2(3)4/h1-2,6-7,16,22-26,40H,3-5,8-15,17-18H2,(H2,36,51)(H,41,52)(H,42,47)(H,43,48)(H,44,53)(H,45,54)(H,49,50)(H4,37,38,39);1H3,(H,3,4)/t22-,23-,24-,25-,26-;/m0./s1 |
InChi Key | KWKBRYJYRIUYEI-QMYFOHRPSA-N |
Canonical SMILES | CC(=O)O.C1CC2C(=O)NC(CSSCCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N |
Isomeric SMILES | CC(=O)O.C1C[C@H]2C(=O)N[C@@H](CSSCCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N |
WGK Germany | 3 |
RTECS | HA0849000 |
关联CAS | 148031-34-9/1248559-53-6/188627-80-7 |
PubChem CID | 12001375 |
分子量 | 831.96 (free base basis) |
Beilstein号 | 9608167 |
溶解性 | Soluble in water (5 mg/ml). |
---|---|
密度 | 1.62 g/cm3(Predicted) |
敏感性 | 对湿度敏感 |
折光率 | n20D1.74 (Predicted) |
分子量 | 892.000 g/mol |
XLogP3 | |
氢键供体数Hydrogen Bond Donor Count | 11 |
氢键受体数Hydrogen Bond Acceptor Count | 14 |
可旋转键计数Rotatable Bond Count | 10 |
精确质量Exact Mass | 891.337 Da |
单同位素质量Monoisotopic Mass | 891.337 Da |
拓扑极表面积Topological Polar Surface Area | 414.000 Ų |
重原子数Heavy Atom Count | 61 |
形式电荷Formal Charge | 0 |
复杂度Complexity | 1550.000 |
同位素原子数Isotope Atom Count | 0 |
定义的原子立体中心计数Defined Atom Stereocenter Count | 5 |
未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
所有立体化学键的总数The total count of all stereochemical bonds | 0 |
共价键合单元计数Covalently-Bonded Unit Count | 2 |
WGK Germany | 3 |
---|---|
RTECS | HA0849000 |
RIDADR | NONHforallmodesoftransport |